NEOGEN CORP is 1.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($2.00 B vs $1.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NTLA | NEOG |
|---|---|---|
| Market cap | $1.70 B | $2.00 B |
| US-listed rank | #2213 | #2099 |
| Revenue (latest FY) | $67.67M | $894.66M |
| Net income (latest FY) | -$412.69M | -$1.09B |
| Net margin | -609.9% | -122.1% |
| SEC filings | 687 | 1,896 |
NEOGEN CORP is 1.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($2.00 B vs $1.70 B).
In their latest fiscal years, Intellia Therapeutics, Inc. reported $67.67M in revenue while NEOGEN CORP reported $894.66M.
Full pages: Intellia Therapeutics, Inc. and NEOGEN CORP, or browse the full rankings.